Use of ECDI-fixed Cell Tolerance As a Method for Preventing Allograft Rejection

The present invention provides methods, systems, and compositions for inducing donor-specific tolerance. In particular, the present invention provides methods of administering ECDI-treated cells before, during, and/or after administration of donor transplant cells or a donor allograft in order to induce tolerance for the cells and/or allograft in a recipient.

Attached files:


Patents:
US 20,110,064,709   [MORE INFO]

Inventor(s): MILLER STEPHEN D [US]; LUO XUNRONG [US]

Type of Offer: Licensing



« More Medical Patents

---